MCC950(CP-456773) NLRP3 抑制剂 ,98%

N-((1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl)-4-(2-hydroxypropan-2-yl)furan-2-sulfonamide
别名: MCC950
Cas号: 210826-40-7 物化性质:
分子式: C20H24N2O5S 熔点:
分子量: 404.4800 沸点:
EINECS编号: 密度:
MDL号: 储存条件:

中文名称:MCC950(CP-456773)NLRP3 抑制剂
CAS号:210826-40-7
中文别名:MCC950
英文名称:N-((1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl)-4-(2-hydroxypropan-2-yl)furan-2-sulfonamide
分子式:C20H24N2O5S
分子量:404.48
MCC950是一种NOD样受体蛋白3(NLRP3)炎症小体激活抑制剂[1]。它抑制LPS预处理小鼠骨髓衍生巨噬细胞(BMDMs)中ATP诱导的IL-1β释放(IC50 = 7.5 nM),以及在Pam3CSK4预处理小鼠BMDMs时在0.1和1 μM浓度下的细胞质LPS诱导的IL-1β释放,表明它能够抑制NLRP3炎症小体的经典和非经典激活[1]。MCC950对NLRP3的选择性比NLRC4更高,在黑色素瘤2(AIM2)炎症体中没有表现出作用,在10μM浓度下不抑制小鼠骨髓源性巨噬细胞中LPS诱导的NLRP3前刺激[1]。它可在浓度为1μM时减少氧化低密度脂蛋白诱导的caspase-1活性,并抑制THP-1巨噬细胞的焦亡[2]。MCC950(10 mg/kg)可降低经左冠状动脉结扎所致的小鼠心肌梗死后心肌纤维化[3]。同样剂量的MCC950可改善脊髓压迫损伤小鼠模型的前肢握力和减轻脊髓水肿
溶解度 DMSO : ≥ 28 mg/mL (69.22 mM) 
储存条件 Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request


 
搜索质检报告(COA)
搜索MSDS
...

MCC950(CP-456773) NLRP3 抑制剂
MCC950(CP-456773);MCC950;MCC-950;CP-456773;N-[[(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-2-furansulfonamide;6RS86E2BWQ;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[4-(2-hydroxypropan-2-yl)furan-2-yl]sulfonylurea;N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-4-(2-hydroxypropan-2-yl)furan-2-sulfonamide;DSSTox_CID_27301;DSSTox_RID_82252;DSSTox_GSID_47301;GTPL8228;BCP15729;Tox21_300462;BDBM5015